References
- Wu PE, Juurlink DN. Clinical review: loperamide toxicity. Ann Emerg Med. 2017;70:245–252.
- MacDonald R, Heiner J, Villarreal J, et al. Loperamide dependence and abuse. BMJ Case Rep. 2015;2015:bcr2015209705.
- Jaffe JH, Kanzler M, Green J. Abuse potential of loperamide. Clin Pharmacol Ther. 1980;28:812–819.
- Korey A, Zilm DH, Sellers EM. Dependence liability of two antidiarrheals, nufenoxole and loperamide. Clin Pharmacol Ther. 1980;27:659–664.
- Daniulaityte R, Carlson R, Falck R, et al. I just wanted to tell you that loperamide WILL WORK: a web-based study of extra-medical use of loperamide. Drug Alcohol Depend. 2013;130:241–244.
- Sklerov J, Levine B, Moore KA, et al. Tissue distribution of loperamide and N-desmethylloperamide following a fatal overdose. J Anal Toxicol. 2005;29:750–754.
- Upton R. Cerebral uptake of drugs in humans. Clin Exp Pharmacol Physiol. 2007;34:695–701.
- Wightman RS, Hoffman RS, Howland MA, et al. Not your regular high: cardiac dysrhythmias caused by loperamide. Clin Toxicol. 2016;54:454–458.
- Eggleston W, Nacca N, Marraffa JM. Loperamide toxicokinetics: serum concentrations in the overdose setting. Clin Toxicol. 2015;53:495–496.
- Streel B, Ceccato A, Klinkenberg R, et al. Validation of a liquid chromatographic-tandem mass spectrometric method for the determination of loperamide in human plasma. J Chromatogr B Anal Technol Biomed Life Sci. 2005;814:263–273.
- Rasla S, St Amand A, Garas MK, et al. Unexpected serious cardiac arrhythmias in the setting of loperamide abuse. R I Med J (2013). 2017;100:33–36.
- Akel T, Bekheit S. Loperamide cardiotoxicity: a brief review. Ann Noninvasive Electrocardiol. 2017;23(August):1–4.
- Enakpene EO, Riaz I, Bin, et al. The long QT teaser: loperamide abuse. Am J Med. 2015;128:1083–1086.
- Sangalli F, Patroniti N, Pesenti A. ECMO in drug intoxication. ECMO-extracorporeal life support adults. 2014;1:1–489.
- Sponholz C, Matthes K, Rupp D, et al. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure - a prospective, randomised crossover study. Crit Care. 2016;20:1–13.
- Imodium (loperamide) for over-the-counter use: drug safety communication - FDA limits packaging to encourage safe use; 2018. Available from: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm594403.htm. Accessed March 5, 2018.